Posterior reversible encephalopathy syndrome (PRES) is characterized by a group of central nervous system related symptoms. Diagnosis is usually made by computed tomography or magnetic resonance imaging. Common causes can be arterial hypertension, sepsis, autoimmune disorders, and medications. We report PRES in a relapsed Hodgkin's Lymphoma patient after a dose of pembrolizumab.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1078155215620922 | DOI Listing |
Publication Analysis
Top Keywords
posterior reversible
8
reversible encephalopathy
8
encephalopathy syndrome
8
relapsed hodgkin's
8
hodgkin's lymphoma
8
syndrome pembrolizumab
4
pembrolizumab therapy
4
therapy relapsed
4
lymphoma posterior
4
syndrome pres
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!